TIORFAN
Bioprojet Pharma
| Research |
OneLook
Acronym Finder
|
| Serial Number | 75354181 |
| Registration Number | 2627043 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Cancellation Code | 2 |
| Domestic Representative | Carol J. Ney |
| Attorney Name | Carol J. Ney |
| Law Office Assigned | M60 |
| Employee Name | EDWARDS, ALICIA COLLIN |
Timeline
| 1997-09-09 | Application Filed |
| 2002-07-09 | Published for Opposition |
| 2002-10-01 | Trademark Registered |
| 2008-02-04 | Location: SCANNING ON DEMAND |
| 2013-05-03 | Cancelled |
| 2013-05-03 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  BIOPROJET PHARMA |
| Address | 9, Rue Rameau 75002 Paris FR |
| Legal Entity Type | Corporation |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical and medicinal preparations and substances for the treatment of gastrointestinal diseases |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 1998-04-22 | 1 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION MAILED | 1998-05-07 | 2 CNRT F:First Action |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 1998-12-17 | 3 CNSA P: |
| NOTICE OF PUBLICATION | 1999-02-19 | 4 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 1999-03-23 | 5 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 1999-06-15 | 6 NOAM O:Outgoing Correspondence |
| NOTICE OF ALLOWANCE CANCELLED | 1999-12-15 | 7 IUCN S: |
| Sec. 1(B) CLAIM DELETED | 1999-12-28 | 8 1.BD I:Incoming Correspondence |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2001-04-10 | 9 ZZZX Z:Deletion |
| NON-FINAL ACTION MAILED | 2001-04-11 | 10 CNRT F:First Action |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2001-08-09 | 11 CRFA I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2001-12-14 | 12 CNSA P: |
| Sec. 1(B) CLAIM DELETED | 2001-12-26 | 13 1.BD I:Incoming Correspondence |
| NOTICE OF PUBLICATION | 2002-06-19 | 14 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2002-07-09 | 15 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2002-10-01 | 16 R.PR A:Allowance for Publication |
| TEAS SECTION 8 RECEIVED | 2007-10-04 | 17 ES8R I:Incoming Correspondence |
| REGISTERED - SEC. 8 (6-YR) FILED | 2007-10-04 | 18 8.AF I:Incoming Correspondence |
| ASSIGNED TO PARALEGAL | 2007-10-15 | 19 PLGL A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED | 2007-10-24 | 20 8.OK O:Outgoing Correspondence |
| CASE FILE IN TICRS | 2008-02-04 | 21 CFIT O:Outgoing Correspondence |
| CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | 2013-05-03 | 22 CAEX O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TIORFAN 85759653 4357653 Live/Registered |
BIOPROJET PHARMA 2012-10-22 |
 TIORFAN 75354181 2627043 Dead/Cancelled |
BIOPROJET PHARMA 1997-09-09 |
 TIORFAN 74158037 1712979 Dead/Cancelled |
BIOPROJET 1991-04-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 